Healthcare - Biotechnology - NASDAQ - US
$ 41.11
0.171 %
$ 2.45 B
Market Cap
15.0
P/E
Price Target
Average
7.03%
Revenue Forecast
Estimate
44.45%
EBIT
Estimate
--29.24%
Net Income
Estimate
26.03%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Protagonist Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for PTGX of $44 , with forecasts ranging from a low of $38 to a high of $50 .
PTGX Lowest Price Target
Wall Street Target
38 USD
-7.57%
PTGX Average Price Target
Wall Street Target
44 USD
7.03%
PTGX Highest Price Target
Wall Street Target
50 USD
21.62%
REVENUE FORECAST
Revenue Forecast Chart PTGX
EBIT FORECAST
EBIT Forecast Chart PTGX
NET INCOME FORECAST
Net Income Chart PTGX